Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: John Arnold, Joel Greenblatt & Kenneth Tropin

Page 1 of 2

John Arnold Gives $2.8-Million to Nonprofit News Outlet (Philanthropy)
The Center for Public Integrity, which won journalism’s prestigious Pulitzer Prize earlier this year, has been awarded a $2.8-million gift that will help it expand operations, the International Business Times reports. The donor is John Arnold, a Houston-based former hedge-fund manager who made made his wealth trading natural gas. Under the Laura and John Arnold Foundation, Mr. Arnold and his wife have pledged or given away 10s of millions of dollars in recent years.

John Arnold

California Hedge Fund Manager Gets 14 Months For “Side Pocket” Investments (HedgeCo)
Former Bay Area hedge fund manager and philanthropist Lawrence Goldfarb has received a sentence of over a year behind bars for concealing more than $12 million in investment proceeds that was owed to investors in his fund. In 2011 Goldfarb agreed to pay more than $14 million to settle the charges, however, he failed to make the payments. The FBI said: “The Court determined that instead of paying the agreed upon restitution and disgorgement, Goldfarb spent hundreds of thousands of dollars on various personal indulgences, including Golden State Warriors season tickets, private air travel, and vacations.”

Greenblatt on the Valuation Dichotomy (TheGuruInvestor)
Hedge fund guru Joel Greenblatt says he’s seeing a wide disparity in the way the current market values large stocks and small stocks. Greenblatt tells Barron’s that, according to his valuation method, the Russell 2000 index of smaller stocks is in the 5th-most-expensive percentile over the past 23 or so years. When priced at these levels, stocks have gone on to lose an average of 3 to 4 percent over the next year. The Russell 1000 index of larger stocks, meanwhile, is only in the 36th-most-expensive percentile using that same timeframe. Historically, when stocks have been priced at that level, they have gone on to gain between 6 and 11 percent, on average, over the next year, Greenblatt said. Greenblatt also talked about his overall investing approach, and how he values stocks.

Quad Advisors debuts hedge fund incubator and accelerator (HedgeWeek)
Quad Advisors provides small and mid-size hedge funds a scalable trading platform, in-house analyst research, risk assessment, accounting and technology services, as well as access to Quad and investor capital. “This is the next step in the continuing evolution of Quad,” says John Guarino, managing partner of Quad. “Hedge funds we accept into Quad Advisors have instant access to capital and benefit from our lower cost and expense structure. We view this as a natural extension of our business, and a prelude to additional initiatives in the future.”

Rothstein Investors Say Hedge Fund Deal Doesn’t Bar Claims (Law360)
A group of investors in a feeder fund of jailed attorney Scott Rothstein’s $1.2 billion Ponzi scheme on Tuesday fought back against hedge fund managers who say that their $32 million deal with Rothstein’s bankrupt law firm bar the investors’ state court claims. The investors, known as the FEP Group, filed an opposition to the hedge funds’ motion to enforce a release in the $32 million deal with the estate of Rothstein Rosenfeldt Adler PA, arguing that the general release was with the estate and that…

Ocwen lower after downgrade (CNBC)

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!